Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPRC | P08575 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 2/20 | 0.38 |
| ▸ | DRD1 | P21728 | 2/20 | 0.38 |
| ▸ | MLNR | O43193 | 1/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17108438 | 0.79 | NQO1 (0.33) | — | |
| SCHEMBL17108440 | 0.75 | — | — | |
| SCHEMBL283246 | 0.75 | HTR2A (0.48) | HTR2ADRD1MLNRNR1I2CHRM2 | |
| SCHEMBL29363404 | 0.75 | HTR2A (0.48) | HTR2ADRD1MLNRNR1I2CHRM2 | |
| SCHEMBL31358795 | 0.74 | ALDH1A1 (0.33) | MEN1KMT2ATDP1PDK2 | |
| SCHEMBL20850092 | 0.74 | PDK2 (0.36) | HTR2AHTR2CPGRPDK2 | |
| SCHEMBL24729587 | 0.73 | HTR2A (0.47) | HTR2ADRD1MLNRNR1I2CHRM2 | |
| SCHEMBL28942003 | 0.73 | HTR2A (0.47) | HTR2ADRD1MLNRNR1I2CHRM2 | |
| Lithium SCHEMBL30363455 | 0.73 | HTR2A (0.47) | HTR2ADRD1MLNRNR1I2CHRM2 | |
| Benzene SCHEMBL28919541 | 0.73 | PGR (0.48) | HTR2ADRD1MLNRNR1I2CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10370473-B2 | Compound, curable composition, cured product, optical member, and lens | FUJIFILM CORPORATION (JP) | 2019-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10370473-B2 | Compound, curable composition, cured product, optical member, and lens | CRYZ, CRYAA, UACA | PTPRC 4576/4885HTR2A 3473/4885DRD1 1926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.